Conduct interim assessment of the EscharEx phase 2 study
Delivered after the deadline (28 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- 28 Jul 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“reiterates its expectation for an interim assessment in mid-2021”
What we found
Evidence strength A What the grades mean
The company announced the positive outcome of the interim assessment on July 28, 2021, which occurred shortly after the mid-2021 deadline.
-
A MediWound Ltd. 6-K filed 2021-07-28
“MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced a positive outcome from a planned interim sample size re-estimation of its ongoing EscharEx® U.S. phase 2 adaptive desig” ✓ confirmed on the page
Market reaction: the shares moved -7.2% against the S&P 500 over the three sessions around the disclosure (27 Jul 2021 to 30 Jul 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Project other
- Indicative materiality
- Low rules
- Action
- Conduct
- Deliverable
- interim assessment of EscharEx phase 2 study
- In the company’s control
- High
- Specificity
- High
- Depends on
- Customer
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you MediWound Ltd.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-MDWD-021498 · Corrections policy